Clinical Research Directory
Browse clinical research sites, groups, and studies.
NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice
Sponsor: Novartis Pharmaceuticals
Summary
This is a prospective, non-interventional, multicenter study to evaluate the efficacy and safety of iptacopan in patients with PNH in real-world settings in Russia.
Official title: A Prospective, Non-interventional Study to Evaluate the Efficacy and Safety of Iptacopan in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) in Routine Clinical Practice in the Russian Federation
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
6
Start Date
2025-07-29
Completion Date
2025-12-25
Last Updated
2026-04-13
Healthy Volunteers
No
Conditions
Locations (5)
Novartis Investigative Site
Syktyvkar, Komi, Russia
Novartis Investigative Site
Grozny, Russia
Novartis Investigative Site
Moscow, Russia
Novartis Investigative Site
Murmansk, Russia
Novartis Investigative Site
Yuzhno-Sakhalinsk, Russia